Nociceptin receptor: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
''' | == Nociceptin Receptor == | ||
[[File:8F7X_Nociceptin_receptor.png|thumb|right|Structure of the nociceptin receptor]] | |||
The '''nociceptin receptor''', also known as the '''opioid receptor-like 1''' ('''ORL-1'''), is a [[G protein-coupled receptor]] (GPCR) that is encoded by the [[OPRL1]] gene in humans. It is a member of the opioid receptor family, which includes the [[mu-opioid receptor]], [[delta-opioid receptor]], and [[kappa-opioid receptor]]. However, the nociceptin receptor is unique in that it does not bind traditional opioid peptides but instead binds the endogenous peptide [[nociceptin]], also known as orphanin FQ. | |||
== Structure == | |||
The nociceptin receptor is a typical GPCR with seven transmembrane domains. It shares significant sequence homology with other opioid receptors but has distinct pharmacological properties. The receptor is coupled to [[G proteins]] that inhibit [[adenylate cyclase]], leading to a decrease in the intracellular concentration of [[cyclic AMP]]. | |||
== Function == | == Function == | ||
The nociceptin receptor is | The primary function of the nociceptin receptor is to modulate pain and analgesia. Unlike classical opioid receptors, activation of the nociceptin receptor by its ligand, nociceptin, can produce both analgesic and anti-analgesic effects depending on the context and location within the [[central nervous system]]. | ||
=== Pain Modulation === | |||
Nociceptin and its receptor play a complex role in pain modulation. In some cases, activation of the nociceptin receptor can lead to analgesia, while in others, it can enhance pain perception. This dual role is thought to be due to the receptor's ability to modulate the release of other neurotransmitters and interact with other pain pathways. | |||
=== Other Functions === | |||
Beyond pain modulation, the nociceptin receptor is involved in a variety of physiological processes, including: | |||
* Regulation of [[mood]] and [[anxiety]] | |||
* Control of [[appetite]] and [[food intake]] | |||
* Modulation of [[reward]] and [[addiction]] pathways | |||
* Influence on [[cardiovascular]] and [[respiratory]] functions | |||
== | == Ligands == | ||
The primary endogenous ligand for the nociceptin receptor is [[nociceptin]], a 17-amino acid peptide. Several synthetic ligands have been developed to target the nociceptin receptor, including both agonists and antagonists, which are used in research to explore the receptor's function and potential therapeutic applications. | |||
== | == Clinical Significance == | ||
The nociceptin receptor is a target of interest for the development of new analgesics that do not have the addictive properties of traditional opioids. Additionally, due to its role in mood regulation, it is being studied for potential treatments for [[depression]] and [[anxiety disorders]]. | |||
== Related Pages == | |||
* [[Opioid receptor]] | * [[Opioid receptor]] | ||
* [[Nociceptin]] | * [[Nociceptin]] | ||
* [[G protein-coupled receptor]] | * [[G protein-coupled receptor]] | ||
* [[Pain management]] | |||
{{Opioid receptor}} | |||
[[Category:Opioid receptors]] | |||
[[Category:G protein-coupled receptors]] | [[Category:G protein-coupled receptors]] | ||
Latest revision as of 16:24, 16 February 2025
Nociceptin Receptor[edit]
The nociceptin receptor, also known as the opioid receptor-like 1 (ORL-1), is a G protein-coupled receptor (GPCR) that is encoded by the OPRL1 gene in humans. It is a member of the opioid receptor family, which includes the mu-opioid receptor, delta-opioid receptor, and kappa-opioid receptor. However, the nociceptin receptor is unique in that it does not bind traditional opioid peptides but instead binds the endogenous peptide nociceptin, also known as orphanin FQ.
Structure[edit]
The nociceptin receptor is a typical GPCR with seven transmembrane domains. It shares significant sequence homology with other opioid receptors but has distinct pharmacological properties. The receptor is coupled to G proteins that inhibit adenylate cyclase, leading to a decrease in the intracellular concentration of cyclic AMP.
Function[edit]
The primary function of the nociceptin receptor is to modulate pain and analgesia. Unlike classical opioid receptors, activation of the nociceptin receptor by its ligand, nociceptin, can produce both analgesic and anti-analgesic effects depending on the context and location within the central nervous system.
Pain Modulation[edit]
Nociceptin and its receptor play a complex role in pain modulation. In some cases, activation of the nociceptin receptor can lead to analgesia, while in others, it can enhance pain perception. This dual role is thought to be due to the receptor's ability to modulate the release of other neurotransmitters and interact with other pain pathways.
Other Functions[edit]
Beyond pain modulation, the nociceptin receptor is involved in a variety of physiological processes, including:
- Regulation of mood and anxiety
- Control of appetite and food intake
- Modulation of reward and addiction pathways
- Influence on cardiovascular and respiratory functions
Ligands[edit]
The primary endogenous ligand for the nociceptin receptor is nociceptin, a 17-amino acid peptide. Several synthetic ligands have been developed to target the nociceptin receptor, including both agonists and antagonists, which are used in research to explore the receptor's function and potential therapeutic applications.
Clinical Significance[edit]
The nociceptin receptor is a target of interest for the development of new analgesics that do not have the addictive properties of traditional opioids. Additionally, due to its role in mood regulation, it is being studied for potential treatments for depression and anxiety disorders.
